Mitochondria-Targeted Triphenylphosphonium-Hydroxytyrosol Prevents Lipotoxicity-Induced Endothelial Injury by Enhancing Mitochondrial Function and Redox Balance via Promoting FoxO1 and Nrf2 Nuclear Translocation and Suppressing Inflammation via Inhibiting p38/NF-кB Pathway.
Xuyun LiuJing GaoYizhen YanEleftheria A GeorgiouJing LouMengya FengXing ZhangFeng GaoJiankang LiuIoannis K KostakisLin ZhaoPublished in: Antioxidants (Basel, Switzerland) (2023)
Hyperlipidemia results in endothelial dysfunction, which is intimately associated with disturbed mitochondrial homeostasis, and is a real risk factor for cardiovascular diseases (CVDs). Triphenylphosphonium (TPP + )-HT, constructed by linking a mitochondrial-targeting moiety TPP + to hydroxytyrosol (HT), enters the cell and accumulates in mitochondria and is thus an important candidate drug for preventing hyperlipidemia-induced endothelial injury. In the present study, we found that TPP-HT has a better anti-inflammatory effect than HT. In vivo, TPP-HT significantly prevented hyperlipidemia-induced adverse changes in the serological lipid panel, as well as endothelial and mitochondrial dysfunction of the thoracic aorta. Similarly, in vitro, TPP-HT exhibited similar protective effects in palmitate (PA)-induced endothelial dysfunction, particularly enhanced expression of the mitochondrial ETC complex II, recovered FoxO1 expression in PA-injured human aorta endothelial cells (HAECs) and promoted FoxO1 nuclear translocation. We further demonstrated that FoxO1 plays a pivotal role in regulating ATP production in the presence of TPP-HT by using the siFoxO1 knockdown technique. Simultaneously, TPP-HT enhanced Nrf2 nuclear translocation, consistent with the in vivo findings of immunofluorescence, and the antioxidant effect of TPP-HT was almost entirely blocked by siNrf2. Concomitantly, TPP-HT's anti-inflammatory effects in the current study were primarily mediated via the p38 MAPK/NF-κB signaling pathway in addition to the FoxO1 and Nrf2 pathways. In brief, our findings suggest that mitochondria-targeted TPP-HT prevents lipotoxicity induced endothelial dysfunction by enhancing mitochondrial function and redox balance by promoting FoxO1 and Nrf2 nuclear translocation.
Keyphrases
- signaling pathway
- oxidative stress
- endothelial cells
- high glucose
- diabetic rats
- pi k akt
- transcription factor
- drug induced
- cell death
- poor prognosis
- induced apoptosis
- anti inflammatory
- cardiovascular disease
- epithelial mesenchymal transition
- type diabetes
- adipose tissue
- spinal cord
- metabolic syndrome
- reactive oxygen species
- inflammatory response
- aortic valve
- coronary artery disease
- coronary artery
- skeletal muscle
- cell proliferation
- fatty acid
- cardiovascular events
- pulmonary artery
- toll like receptor
- long non coding rna
- pulmonary arterial hypertension